Symmetry Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-8,482
Closed -$221K – 556
2022
Q1
$221K Hold
8,482
– – 0.01% 550
2021
Q4
$241K Hold
8,482
– – 0.02% 565
2021
Q3
$273K Hold
8,482
– – 0.02% 572
2021
Q2
$294K Hold
8,482
– – 0.02% 572
2021
Q1
$250K Hold
8,482
– – 0.02% 595
2020
Q4
$260K Sell
8,482
-2,915
-26% -$88.9K 0.02% 547
2020
Q3
$318K Buy
+11,397
New +$289K 0.03% 469

Other funds holding ELAN

Symmetry Partners's ELAN Position: Q2 2022 in Review

Symmetry Partners sold out of Elanco Animal Health (ELAN) in Q2 2022, closing a stake of 8,482 shares — an estimated $221K sold.

Symmetry Partners first reported a position in ELAN in Q3 2020 and held it in 7 quarters. The position peaked at $318K in Q3 2020. 438 funds tracked by Wall St. Rank hold ELAN as of Q2 2022.

  • Symmetry Partners reported no remaining Elanco Animal Health position as of Q2 2022 after selling out during the quarter.
  • Symmetry Partners sold 8,482 Elanco Animal Health shares in Q2 2022, an estimated $221K.
  • Symmetry Partners first reported a position in Elanco Animal Health in Q3 2020 and held it in 7 quarters.
  • Symmetry Partners's Elanco Animal Health position peaked at $318K in Q3 2020.
  • 438 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2022.

Based on Symmetry Partners's 13F filing for Q2 2022, filed 11 Jul 2022.